Transcutaneous Electrical Nerve Stimulation With Frequency Specific Microcurrent Resonance Therapy for Non Specific Chronic Low Back Pain Patents: a Prospective Double Blinded, Randomized, Placebo Control Trial

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-09-01

Study Completion Date

2021-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Transcutaneous electrical nerve stimulation (TENS) is widely used for chronic pain. Recent studies showed frequency-specific microcurrent (FSM) resonant therapy was safe and effective in patients with non-specific chronic low back pain. However, there was no prospective, double-blinded randomized controlled trial to validate the clinical applicability. The goal of this trial is to verify safety and efficacy of FSM using a TENS device, Dragon Waves Resonant Home Care Electronic Nerve Stimulator-DW1330,(Taiwan Resonant Waves Research Co, Taiwan R.O.C), in 60 patients with non-specific low back pain.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Randomized Blinded Evaluation of the Effects of TENS and IFC Compared to a Sham Device and SOC in Patients With Non-Specific CLBP

NCT05972889

Non-Specific Chronic Lower Back Pain

COMPLETED NA

A Study to Confirm the Safety of High Frequency DRG Stimulator in Patients With Chronic Lower Limb Pain

NCT03285113

Failed Back Surgery Syndrome Complex Regional Pain Syndrome (CRPS)

COMPLETED NA

High Tone Power Therapy on Lumbosacral Radiculopathy Patients

NCT07305792

Radiculopathy Lumbar

RECRUITING NA

Overcoming Analgesic Tolerance to TENS

NCT03475082

Pain

COMPLETED NA

Electrical Muscle Stimulation on Muscle Mass, Strength, and Body Composition

NCT06036953

Electrical Muscle Stimulation Exercise Resistance Training

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Several studies showed that frequency-specific microcurrent (FSM) resonance therapy delivered by transcutaneous electrical nerve stimulation (TENS) device is safe and effective in patients with non-specific low back pain. The regiment of variable-frequency combination (1-10000 Hz or 1-20000 Hz), continuous use for 36-60 mins per day and 30 to 180 days per session has been proven to be safe. To validate the clinical applicability of FSM by using a TENS device, DW-1330 (Taiwan Resonant Waves Research Co., Taiwan R.O.C.), a prospective, randomized, double-blinded trial is proposed. Investigators are going to recruit 60 patients with non-specific low back pain for at least 3 months. Clinical assessments include Numerical Rating Scale (NRS), Oswestry Disability Index (ODI), EuroQol instrument (EQ-5D), Pressure pain threshold (PPT), and Heart rate variability (HRV). The 60 patients were double-blinded, 1:1:1-randomly-distributed into 3 groups using different variable-frequency combinations: (1) Variable-frequency combination 1 (2) Variable-frequency combination 2 (3) Control(Placebo). During the surveillance period, a total of 2 visits and a telephone follow-up is set at Time point = 0, 2(telephone) and 4 week after recruitment. The primary endpoint is the change of NRS. The secondary endpoint is change of Heart rate variability (HRV). The safety evaluated index is the adverse event rate for all 3 groups.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non Specific Chronic Low Back Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Variable-frequency combination 1

Non disclosure

Group Type EXPERIMENTAL

Transcutaneous electrical nerve stimulation with frequency-specific microcurrent resonant therapy

Intervention Type DEVICE

Transcutaneous electrical nerve stimulation with frequency-specific microcurrent resonant therapy using (Dragon Waves Resonant Home Care Electronic Nerve Stimulator (DW-1330), Taiwan Resonance Wave Research Co., Taiwan R.O.C,)

Variable-frequency combination 2

Non disclosure

Group Type ACTIVE_COMPARATOR

Transcutaneous electrical nerve stimulation with frequency-specific microcurrent resonant therapy

Intervention Type DEVICE

Transcutaneous electrical nerve stimulation with frequency-specific microcurrent resonant therapy using (Dragon Waves Resonant Home Care Electronic Nerve Stimulator (DW-1330), Taiwan Resonance Wave Research Co., Taiwan R.O.C,)

Control (Placebo)

Non-disclosure

Group Type PLACEBO_COMPARATOR

Transcutaneous electrical nerve stimulation with frequency-specific microcurrent resonant therapy

Intervention Type DEVICE

Transcutaneous electrical nerve stimulation with frequency-specific microcurrent resonant therapy using (Dragon Waves Resonant Home Care Electronic Nerve Stimulator (DW-1330), Taiwan Resonance Wave Research Co., Taiwan R.O.C,)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Transcutaneous electrical nerve stimulation with frequency-specific microcurrent resonant therapy

Transcutaneous electrical nerve stimulation with frequency-specific microcurrent resonant therapy using (Dragon Waves Resonant Home Care Electronic Nerve Stimulator (DW-1330), Taiwan Resonance Wave Research Co., Taiwan R.O.C,)

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age between 20-80 years old, male or female.
2. Cases with normal psychological and communication functions who can cooperate with our study.
3. Cases who are willing to sign permits and cooperate with our study including follow up and examination.
4. Cases with complete clinical data and willing to accept investigation.

Exclusion Criteria

1. Cases who diagnose pregnancy within 12 months before included.
2. Cases who diagnose with malignant disease.
3. Cases with a history of epilepsy.
4. Cases who diagnose with fracture without fixation.
5. Cases who diagnose with impaired sensation or psychological function.
6. Cases whose skin condition is not feasible to accept treatment.
7. Cases with pacemaker.
8. Cases who allergic to the conductive medium
9. Cases with a major psychiatric disorder such as schizophrenia or bipolar disorder.
10. Cases with severe visual or auditory disorder.
11. Cases who cannot communicate with the Mandarin language.
12. Other mental diseases are not suitable assessed by the PI

Minimum Eligible Age

20 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes